Facial subcutaneous dermatofibrosarcoma protuberans treated with imatinib and monitored with magnetic resonance: A therapeutic alternative for unresectable cases Research Letter

  

Authors:	Navarrete-Dechent, C.; Shah, K.; Mori, S.; Gounder, M. M.; Stambuk, H. E.; Nehal, K. S.
Title:	Facial subcutaneous dermatofibrosarcoma protuberans treated with imatinib and monitored with magnetic resonance: A therapeutic alternative for unresectable cases
Keywords:	immunohistochemistry; adult; clinical article; human tissue; treatment response; clinical feature; histopathology; case report; unspecified side effect; nuclear magnetic resonance imaging; follow up; letter; imatinib; skin biopsy; skin neoplasms; skin cancer; skin tumor; clinical evaluation; magnetic resonance spectroscopy; nuclear magnetic resonance spectroscopy; spindle cell; clinical decision making; physical examination; cell invasion; muscle cramp; dermatofibrosarcoma; face injury; dermatofibrosarcoma protuberans; imatinib mesylate; benzamide derivative; benzamides; subcutaneous tissue; humans; human; female; clinical monitoring; subcutaneous dermatofibrosarcoma protuberans
Journal Title:	Dermatologic Therapy
Volume:	35
Issue:	6
ISSN:	1396-0296
Publisher:	Wiley Blackwell
Date Published:	2022-06-01
Start Page:	e15446
Language:	English
DOI:	10.1111/dth.15446
PUBMED:	35293090
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126822325&doi=10.1111%2fdth.15446&partnerID=40&md5=147d04dbbc13528d8889806be984a5df
Notes:	Letter -- Export Date: 1 July 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/195600